GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fonar Corp (NAS:FONR) » Definitions » 5-Year RORE %

Fonar (FONR) 5-Year RORE % : -3.73% (As of Dec. 2023)


View and export this data going back to 1981. Start your Free Trial

What is Fonar 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Fonar's 5-Year RORE % for the quarter that ended in Dec. 2023 was -3.73%.

The industry rank for Fonar's 5-Year RORE % or its related term are showing as below:

FONR's 5-Year RORE % is ranked worse than
61.63% of 172 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.83 vs FONR: -3.73

Fonar 5-Year RORE % Historical Data

The historical data trend for Fonar's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fonar 5-Year RORE % Chart

Fonar Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
5-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.15 -10.19 -13.64 -13.83 -11.38

Fonar Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.47 -16.43 -11.38 -7.36 -3.73

Competitive Comparison of Fonar's 5-Year RORE %

For the Diagnostics & Research subindustry, Fonar's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fonar's 5-Year RORE % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fonar's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Fonar's 5-Year RORE % falls into.



Fonar 5-Year RORE % Calculation

Fonar's 5-Year RORE % for the quarter that ended in Dec. 2023 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( 1.84-2.14 )/( 8.05-0 )
=-0.3/8.05
=-3.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2023 and 5-year before.


Fonar  (NAS:FONR) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Fonar 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of Fonar's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fonar (FONR) Business Description

Traded in Other Exchanges
Address
110 Marcus Drive, Melville, NY, USA, 11747
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue. The company's areas of operations are principally in the United States. It also exports to the United Arab Emirates, England, and Germany.
Executives
Timothy Raymond Damadian director, officer: CEO, President & Treasurer 110 MARCUS DR., MELVILLE NY 11747
Luciano B Bonanni officer: Exec VP, COO & PFO 110 MARCUS DR., MELVILLE NY 11747
Raymond V Damadian director, officer: president 31 FAIRBANKS BLVD, WOODBURY NY 11797
Robert J Janoff director 32 OSAGE DRIVE, HUNTINGTON STATION NY 11746
Data Charles O director 347 LINCOLN AVENUE, BEAVER PA 15009
Claudette Chan director 145 WEST 86TH STREET, APT. 15B, NEW YORK NY 10024
David B Terry officer: Secretary BOX 1439, EAST QUOGUE NY 11942
Robert Djerejian director 303 EAST 57TH STREET, APT 16LA, NEW YORK NY 10022